Clinical Pharmacology of Delafloxacin in Patients With Hepatic Impairment

Delafloxacin is a novel anionic fluoroquinolone with robust activity against Gram‐positive, Gram‐negative, atypical, and anaerobic bacteria, including methicillin‐resistant S aureus. Delafloxacin is currently being studied for the treatment of acute bacterial skin and skin structure infections and c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Clin Pharmacol
Hauptverfasser: Hoover, Randall, Marbury, Thomas C., Preston, Richard A., Quintas, Megan, Lawrence, Laura E., Paulson, Susan K., Luke, David R., Cammarata, Sue K.
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2016
Schlagworte:
Special Populations
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5324641/
https://ncbi.nlm.nih.gov/pubmed/27570245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcph.817
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge